China's listed drug analysis report! 13 medic-related drugs, 8 exclusive varieties, 12 exclusive varieties of the same standard...

Introduction: China's Listed Drug Analysis Report in May 2020point of view:may the drug regulatory bureau added a total of 51 new approvalsadded eight new exclusive varieties in Mayin May, 42 new domestic pharmaceutical approvals and 9 import approvals were addedAccording to the latest statistics of the enterprise version of pharmaceutical data, 51 new approvals will be added in May 2020Figure 1 New approvals for January-May 2020
42 new approvals in May were domestic drugs and 9 were imported drugsSee the details of the new approval below, drug typesin May the Drug Administration added 29 new generic drugs approvals, 1 biological product approval and 21 Chinese medicine approvalsFigure 2 The drug types of the Drug Administration for January-May 2020II, dosage form situationmay FDA approved the first three dosage forms for the pills 21 approvals, tablets 12 approvals (specific new dosage forms see below)Figure 3 In May 2020, the Drug Administration's dosage form, the health insurance category situationmay new approvals of which 13 are 2019 new version of the National Health Insurance Directory class A drugs, 20 approvals belong to the 2019 new version of the National Health Insurance Directory of Class B drugsFigure IV The state of the various medical insurance categories of the Drug Administration in January-May 20204, the number of approvals in each province
in May the new approval production enterprise registration address was first in Guangxi, there are 21Figure V In May 2020 the provinces have the number of approvalsFive, exclusive situation
the same variety has 8 exclusive approvals, details can be found in Table 1Figure 6 The number of exclusive categories of the same varieties in May 2020
Table I Table I May 2020 the same variety exclusive drugdata as of June 2, 2020
the same product regulations exclusive 12 approvals (the same product regulations exclusively contain the same variety exclusive), see table 2Figure 7 May 2020 with the same product regulations exclusive number of categoriesTable II May 2020 with the same rules exclusive drugdata as of June 2, 2020data source: Drug Zhi China listed drug database